Patrick A Kupelian

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi request reprint Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era
    Patrick A Kupelian
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 52:704-11. 2002
  2. ncbi request reprint Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy
    Patrick A Kupelian
    Department of Radiation Oncology, Desk 728, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Clin Oncol 20:3376-85. 2002
  3. ncbi request reprint Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
    Michael E Ray
    Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
    Urology 68:1257-62. 2006
  4. doi request reprint Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration
    Choonik Lee
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Radiother Oncol 89:81-8. 2008
  5. ncbi request reprint PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
    Michael E Ray
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 64:1140-50. 2006
  6. ncbi request reprint Evaluation of an infrared camera and X-ray system using implanted fiducials in patients with lung tumors for gated radiation therapy
    Twyla R Willoughby
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 66:568-75. 2006
  7. doi request reprint Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer
    Rahul D Tendulkar
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Int J Radiat Oncol Biol Phys 87:94-9. 2013
  8. ncbi request reprint Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
    Eric M Horwitz
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer 107:1496-502. 2006
  9. ncbi request reprint Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 70:1146-50. 2008
  10. ncbi request reprint Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 57:629-34. 2003

Detail Information

Publications78

  1. ncbi request reprint Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era
    Patrick A Kupelian
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 52:704-11. 2002
    ..To study the impact of biochemical failure on overall survival rates during the first 10 years after definitive radiotherapy for localized prostate cancer...
  2. ncbi request reprint Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy
    Patrick A Kupelian
    Department of Radiation Oncology, Desk 728, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Clin Oncol 20:3376-85. 2002
    ..To review biochemical relapse-free survival (bRFS) rates after either external-beam radiotherapy (RT) or radical prostatectomy (RP) for localized prostate cancer...
  3. ncbi request reprint Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
    Michael E Ray
    Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
    Urology 68:1257-62. 2006
    ..To determine whether nadir prostate-specific antigen (PSA) levels within 12 months (nadir PSA12) after completion of radiotherapy (RT) can be used as an early marker of recurrence risk...
  4. doi request reprint Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration
    Choonik Lee
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Radiother Oncol 89:81-8. 2008
    ..To assess and evaluate geometrical changes in parotid glands using deformable image registration and megavoltage CT (MVCT) images...
  5. ncbi request reprint PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
    Michael E Ray
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 64:1140-50. 2006
    ....
  6. ncbi request reprint Evaluation of an infrared camera and X-ray system using implanted fiducials in patients with lung tumors for gated radiation therapy
    Twyla R Willoughby
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 66:568-75. 2006
    ..To report on the initial clinical use of a commercially available system to deliver gated treatment using implanted fiducials, in-room kV X-rays, and an infrared camera tracking system...
  7. doi request reprint Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer
    Rahul D Tendulkar
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Int J Radiat Oncol Biol Phys 87:94-9. 2013
    ..We aim to identify the causes of death and factors predictive for mortality in this population...
  8. ncbi request reprint Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
    Eric M Horwitz
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer 107:1496-502. 2006
    ....
  9. ncbi request reprint Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 70:1146-50. 2008
    ..To verify whether rectal distention at the time of planning impacts outcomes in patients with localized prostate cancer treated with daily image guidance...
  10. ncbi request reprint Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 57:629-34. 2003
    ..The purpose of the present study was to study a similar phenomenon with definitive radiotherapy (RT)...
  11. ncbi request reprint Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 68:1424-30. 2007
    ..To study the outcomes in patients treated for localized prostate cancer with 70 Gy delivered at 2.5-Gy/fraction within 5 weeks...
  12. ncbi request reprint Validation of a computational method for assessing the impact of intra-fraction motion on helical tomotherapy plans
    Wilfred Ngwa
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, 1400 South Orange Avenue, Orlando, FL 32806, USA
    Phys Med Biol 54:6611-21. 2009
    ..The profile and gamma analysis results validate the accuracy of this method for incorporating intra-fraction motion into the dose calculation engine for assessment of dosimetric effects on helical tomotherapy dose deliveries...
  13. doi request reprint Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy
    Rahul D Tendulkar
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Int J Radiat Oncol Biol Phys 82:1397-404. 2012
    ..Modern outcomes of high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT) for high-risk (HR) prostate cancer are not well described...
  14. ncbi request reprint Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis
    Eric M Horwitz
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 2497, USA
    J Urol 173:797-802. 2005
    ..In this report we determined the sensitivity and specificity of several BF definitions using distant failure (DF) alone or clinical failure (CF), defined as local failure (LF) and/or DF...
  15. doi request reprint A comparison of soft-tissue implanted markers and bony anatomy alignments for image-guided treatments of head-and-neck cancers
    Omar A Zeidan
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 76:767-74. 2010
    ..Dosimetric impact of the two alignment techniques on target coverage is presented...
  16. ncbi request reprint Dosimetric effect of prostate motion during helical tomotherapy
    Katja M Langen
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 74:1134-42. 2009
    ..To assess the dosimetric consequence of intrafraction prostate motion on helical tomotherapy plans...
  17. ncbi request reprint Evaluation of image-guidance strategies in the treatment of localized prostate cancer
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 70:1151-7. 2008
    ..Using data from patients treated using daily image guidance, the remaining setup errors for several different strategies were retrospectively calculated...
  18. ncbi request reprint Correlation between dosimetric effect and intrafraction motion during prostate treatments delivered with helical tomotherapy
    Katja M Langen
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, 1400 South Orange Av, Orlando, FL 32806, USA
    Phys Med Biol 53:7073-86. 2008
    ..However, when motion management techniques are evaluated, it should be kept in mind that the dosimetric impact of observed prostate motion is small for the majority of fractions...
  19. ncbi request reprint Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 71:16-22. 2008
    ..To study the effect of radiation dose on local failure (LF) and distant metastasis (DM) in prostate cancer patients treated with external beam radiotherapy...
  20. doi request reprint Patient dose from megavoltage computed tomography imaging
    Amish P Shah
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 70:1579-87. 2008
    ..The purpose of this investigation was to show that the MVCT dose can be computed in phantoms, and further, that the dose can be reported for actual patients from MVCT on a helical tomotherapy unit...
  21. doi request reprint Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer
    Michael J Burdick
    Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH 44113, USA
    Int J Radiat Oncol Biol Phys 73:1439-45. 2009
    ..Most of the present data regarding the PG of GS7 CaP refer to surgical specimens. Our goal was to determine whether the biopsy GS used at the time of medical decision making predicted for the biochemical outcome...
  22. doi request reprint Real-time tumor tracking in the lung using an electromagnetic tracking system
    Amish P Shah
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 86:477-83. 2013
    ..To describe the first use of the commercially available Calypso 4D Localization System in the lung...
  23. ncbi request reprint Aggressiveness of familial prostate cancer
    Patrick A Kupelian
    Glickman Urological Institute and Radiation Oncology Department, Cleveland Clinic Foundation, Cleveland, OH, USA
    J Clin Oncol 24:3445-50. 2006
    ..To report on the aggressiveness of sporadic versus familial prostate cancer...
  24. ncbi request reprint Modeling simulation and visualization of conformal 3D lung tumor dosimetry
    Anand Santhanam
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, 1400S Orange Ave, Orlando, FL 32806, USA
    Phys Med Biol 54:6165-80. 2009
    ..The real-time capability enables the framework to be coupled with real-time tumor monitoring systems such as implanted fiducials for computing the dose delivered in real time during the treatment...
  25. ncbi request reprint Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking
    Dale W Litzenberg
    Department of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
    Int J Radiat Oncol Biol Phys 68:1199-206. 2007
    ..Ideally, the distances between transponders remains constant over the course of treatment. In this work, we evaluate the accuracy of these conditions...
  26. ncbi request reprint A model for predicting lung cancer response to therapy
    Rebecca M Seibert
    Department of Radiation Oncology, Thompson Cancer Survival Center, Knoxville, TN 37916, USA
    Int J Radiat Oncol Biol Phys 67:601-9. 2007
    ..The goal of this study was to develop and test a model for predicting lung tumor response during IGRT treatment using serial megavoltage CT (MVCT)...
  27. doi request reprint Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration
    Choonik Lee
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, 1400 South Orange Avenue, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 71:1563-71. 2008
    ..To analyze changes in parotid gland dose resulting from anatomic changes throughout a course of radiotherapy in a cohort of head-and-neck cancer patients...
  28. ncbi request reprint Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 63:1463-8. 2005
    ..To analyze the long-term relapse-free survival and toxicity rates in patients treated with hypofractionated intensity-modulated radiotherapy...
  29. ncbi request reprint Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation
    Louis Potters
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, NY, USA
    Radiother Oncol 71:29-33. 2004
    ....
  30. ncbi request reprint Evaluation of image-guidance protocols in the treatment of head and neck cancers
    Omar A Zeidan
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 67:670-7. 2007
    ..Using data from patients who were treated with daily IG, the residual setup errors for several different protocols are retrospectively calculated...
  31. ncbi request reprint Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer
    Patrick A Kupelian
    Department of Radiation Oncology, The M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 66:876-82. 2006
    ..The aim of this work was to study the variations in delivered doses to the prostate, rectum, and bladder during a full course of image-guided external beam radiotherapy...
  32. ncbi request reprint Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, Florida 32806, USA
    Urology 68:593-8. 2006
    ..To report biochemical relapse-free survival (bRFS) after radiotherapy (RT) for localized prostate cancer with two separate failure definitions and compare the results with those after radical prostatectomy (RP)...
  33. ncbi request reprint Continuing trends in pathological stage migration in radical prostatectomy specimens
    Ithaar H Derweesh
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Urol Oncol 22:300-6. 2004
    ..1% for 1987 to 1994 and 82.6% for 1995 to 2001 (P-value = 0.0022). PSA screening has resulted in a downward pathological stage migration. These observations demonstrate improved biochemical failure rates in more recently treated patients...
  34. ncbi request reprint Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration
    Hadley M Wood
    Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Urol 178:1271-6. 2007
    ..Our hypothesis was that the gap in biochemical relapse-free survival between these groups would lessen in the later prostate specific antigen era due to catch-up awareness/availability of screening and treatment in the black population...
  35. ncbi request reprint Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?
    Deepak Khuntia
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Cancer 100:1283-92. 2004
    ....
  36. ncbi request reprint Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above
    Patrick A Kupelian
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Cancer 95:2302-7. 2002
    ..To review the biochemical recurrence-free survival (bRFS) rates of treatment with either external beam radiotherapy or radical prostatectomy in patients with biopsy Gleason score 8 or above in the prostate specific antigen (PSA) era...
  37. doi request reprint An evaluation of intrafraction motion of the prostate in the prone and supine positions using electromagnetic tracking
    Amish P Shah
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Radiother Oncol 99:37-43. 2011
    ..To evaluate differences in target motion during prostate irradiation in the prone versus supine position using electromagnetic tracking to measure prostate mobility...
  38. ncbi request reprint Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer un
    John Thomas
    Urological Institute, Taussig Cancer Center, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Clin Oncol 20:3213-8. 2002
    ....
  39. ncbi request reprint Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer
    Twyla R Willoughby
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 65:528-34. 2006
    ..This study involves the first human use of the system, to evaluate the localization accuracy of this technique compared with radiographic localization and to assess its ability to obtain real-time prostate-motion information...
  40. ncbi request reprint Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 58:25-33. 2004
    ....
  41. ncbi request reprint Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:915-28. 2003
    ..To report the long-term outcome for patients with Stage T1-T2 adenocarcinoma of the prostate definitively irradiated in the prostate-specific antigen (PSA) era...
  42. ncbi request reprint Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy
    Mary Feng
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 68:1417-23. 2007
    ..To determine the rate and magnitude of late genitourinary (GU) and gastrointestinal (GI) toxicities after salvage or adjuvant radiotherapy (RT) for prostate cancer, and to determine predictive factors for these toxicities...
  43. doi request reprint Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
    Eric A Klein
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Urol Oncol 27:67-71. 2009
    ..The results suggest similar short-term survival but domain-specific effects on QOL after treatment with radical prostatectomy, brachytherapy, or external beam radiotherapy...
  44. ncbi request reprint Daily variations in the position of the prostate bed in patients with prostate cancer receiving postoperative external beam radiation therapy
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 66:593-6. 2006
    ..The aim of this study was to evaluate the extent of the variation in the position of the prostate bed with respect to the bony anatomy...
  45. ncbi request reprint Performance characterization of megavoltage computed tomography imaging on a helical tomotherapy unit
    Sanford L Meeks
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, Florida 32806, USA
    Med Phys 32:2673-81. 2005
    ..In conjunction with the ability to recalculate radiotherapy doses on these images, this enables dose guidance as well as image guidance of radiotherapy treatments...
  46. ncbi request reprint Implantation and stability of metallic fiducials within pulmonary lesions
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 69:777-85. 2007
    ..To report and describe implantation techniques and stability of metallic fiducials in lung lesions to be treated with external beam radiotherapy...
  47. pmc The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans
    Katja M Langen
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, Florida, USA
    Int J Radiat Oncol Biol Phys 84:1220-5. 2012
    ....
  48. ncbi request reprint Observations on real-time prostate gland motion using electromagnetic tracking
    Katja M Langen
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 71:1084-90. 2008
    ..To quantify and describe the real-time movement of the prostate gland in a large data set of patients treated with radiotherapy...
  49. ncbi request reprint Influence of intrafraction motion on margins for prostate radiotherapy
    Dale W Litzenberg
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 65:548-53. 2006
    ..To assess the impact of intrafraction intervention on margins for prostate radiotherapy...
  50. ncbi request reprint Image-guided radiotherapy for localized prostate cancer: treating a moving target
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, 1400 South Orange Avenue, Orlando, FL 32806, USA
    Semin Radiat Oncol 18:58-66. 2008
    ..Understanding and managing the consequences of anatomic variations within the lower pelvis should be a priority in designing and implementing future clinical trials...
  51. ncbi request reprint Pathologic stage migration has slowed in the late PSA era
    Fei Dong
    Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
    Urology 70:839-42. 2007
    ..We examined patients treated by radical prostatectomy between 1987 and 2005 to establish temporal trends in pathologic stage migration as assessed by the proportion of patients with nonorgan-confined disease (NOCD)...
  52. ncbi request reprint A technique for adaptive image-guided helical tomotherapy for lung cancer
    Chester R Ramsey
    Department of Radiation Oncology, Thompson Cancer Survival Center, Knoxville, TN 37916, USA
    Int J Radiat Oncol Biol Phys 64:1237-44. 2006
    ....
  53. ncbi request reprint Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer
    Patrick A Kupelian
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 53:904-12. 2002
    ....
  54. doi request reprint Investigation of accelerated partial breast patient alignment and treatment with helical tomotherapy unit
    Katja M Langen
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 70:1272-80. 2008
    ....
  55. doi request reprint Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis
    Jay P Ciezki
    Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA
    Urology 80:367-72. 2012
    ..To account for lead-time bias, we compared the 10-year metastasis-free survival rate for the prescreening era group (PRE) to the 15-year metastases-free survival rate of the postscreening era group (POST)...
  56. ncbi request reprint Comparison of transabdominal ultrasound and electromagnetic transponders for prostate localization
    Ryan D Foster
    Department of Radiation Oncology, UT Southwestern Medical Center at Dallas, Dallas, TX 75390 9183, USA
    J Appl Clin Med Phys 11:2924. 2010
    ..Our study finds that there are systematic differences between Calypso and ultrasound for prostate localization...
  57. ncbi request reprint Brain metastases from gynecological cancers: factors that affect overall survival
    Ashraf S Mahmoud-Ahmed
    Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic Cancer Center, The Cleveland Clinic, Cleveland, OH 44195 USA
    Technol Cancer Res Treat 1:305-10. 2002
    ..3 months, p=0.017). Our results suggest that patients with a single lesion had improved outcomes. We encourage enrollment of patients with brain metastases onto prospective clinical trials...
  58. ncbi request reprint Initial experience with megavoltage (MV) CT guidance for daily prostate alignments
    Katja M Langen
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 62:1517-24. 2005
    ..Three manual techniques of registering the MVCT images with the planning kilovoltage (kV) CT images were evaluated. The techniques are based on visual alignment of (1) fiducial prostate markers, (2) CT anatomy, and (3) kVCT contours...
  59. ncbi request reprint Localized prostate cancer: radiation or surgery?
    Eric A Klein
    Section of Urology Oncology, Urological Institute, Cleveland Clinic Foundation, Desk A100, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Urol Clin North Am 30:315-30, ix. 2003
    ..The available data suggest that these two modalities provide similar rates of cancer control at 10 years, and that except for the youngest patients, choice of therapy should be based on toxicity and QOL issues...
  60. doi request reprint Expanding the use of real-time electromagnetic tracking in radiation oncology
    Amish P Shah
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, Florida 32806, USA
    J Appl Clin Med Phys 12:3590. 2011
    ..Although there are a number of technical and fiscal issues that need to be addressed, electromagnetic tracking systems are expected to play a continued role in improving the precision of radiation delivery...
  61. ncbi request reprint Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model
    Sean X Cavanaugh
    Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Cancer 101:96-105. 2004
    ....
  62. ncbi request reprint Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
    Patrick A Kupelian
    Department of Radiation Oncology, Cleveland Clinic Foundation, Ohio 44195, USA
    Cancer J 8:62-6. 2002
    ..The purpose of this study was to analyze predictors of late rectal bleeding after external-beam radiotherapy for localized prostate cancer, with a focus on the volume of rectum irradiated...
  63. ncbi request reprint Brain metastases from bladder carcinoma: presentation, treatment and survival
    Ashraf S Mahmoud-Ahmed
    Department of Radiation Oncology, Brain Tumor Institute, Taussig Cancer Center, 9500 Euclid Avenue, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    J Urol 167:2419-22. 2002
    ..We report the presentation of brain metastases from bladder carcinoma. We investigated the role of whole brain radiation therapy for treating this disease...
  64. ncbi request reprint Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment
    Patrick A Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 63:1024-8. 2005
    ....
  65. ncbi request reprint Visualization of 3D volumetric lung dynamics for real-time external beam lung radiotherapy
    Anand P Santhanam
    Department of Radiation Oncology, University of California, Los Angeles, 200 UCLA Medical Plaza, Suite B265 Los Angeles, CA 90095, USA
    Stud Health Technol Inform 163:567-73. 2011
    ..Results show the radiation dose deposited on the lung tumor as well as the surrounding tissues, the combination of which is patient-specific and varies from one treatment fraction to another...
  66. ncbi request reprint Defining sexual outcomes after treatment for localized prostate carcinoma
    Leslie R Schover
    Department of Behavioral Science, The University of Texas M D Anderson Cancer Center, Houston, Texas77030 4009, USA
    Cancer 95:1773-85. 2002
    ..The objective of this survey was to identify factors associated with good sexual outcomes in a large group of survivors of localized prostate carcinoma...
  67. ncbi request reprint Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 27, New York, NY 10021, USA
    J Clin Oncol 21:4568-71. 2003
    ..The goal of this study was to create and to externally validate a nomogram for predicting the probability that a patient will develop metastasis within 5 years after three-dimensional conformal radiation therapy (CRT)...
  68. ncbi request reprint Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    JAMA 291:1325-32. 2004
    ..Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highest risk of metastatic disease progression...
  69. ncbi request reprint Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups
    Howard D Thames
    Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, and Department of Radiation Oncology, William Beaumont Hospital, Deroit, MI, USA
    Int J Radiat Oncol Biol Phys 65:975-81. 2006
    ....
  70. ncbi request reprint Deformable registration of the planning image (kVCT) and the daily images (MVCT) for adaptive radiation therapy
    Weiguo Lu
    TomoTherapy Inc, 1240 Deming Way, Madison, WI 53717, USA
    Phys Med Biol 51:4357-74. 2006
    ..The applications of deformable registration in ART, including 'deformable dose accumulation', 'automatic re-contouring' and 'tumour growth/regression evaluation' throughout the course of radiotherapy are also studied...
  71. ncbi request reprint Finding help for sexual problems after prostate cancer treatment: a phone survey of men's and women's perspectives
    Leah E Neese
    Department of Behavioral Science, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Psychooncology 12:463-73. 2003
    ....
  72. ncbi request reprint Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer
    Markus Graefen
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 20:951-6. 2002
    ..We evaluated the predictive accuracy of the nomogram when applied to patients of four international institutions...
  73. ncbi request reprint Seeking help for erectile dysfunction after treatment for prostate cancer
    Leslie R Schover
    Department of Behavioral Science, M D Anderson Cancer Center, The University of Texas, Houston, Texas 77030 4009, USA
    Arch Sex Behav 33:443-54. 2004
    ..These results suggest that cognitive-behavioral interventions designed to challenge men's negative beliefs about seeking help for ED could potentially increase help-seeking behavior...
  74. ncbi request reprint The use of treatments for erectile dysfunction among survivors of prostate carcinoma
    Leslie R Schover
    Department of Behavioral Science, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 95:2397-407. 2002
    ....
  75. ncbi request reprint Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability
    Patrick A Kupelian
    Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 62:1291-6. 2005
    ..To test this assumption, the intermarker distances (IMD) of implanted markers was monitored during the full course of radiation therapy to determine marker stability within the prostate gland...
  76. ncbi request reprint Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy
    Todd J Scarbrough
    MIMA Cancer Center, Melbourne, FL 32901, USA
    Int J Radiat Oncol Biol Phys 65:378-87. 2006
    ..To analyze two methods of image-guided radiotherapy (IGRT) for external beam radiotherapy of prostate cancer...
  77. ncbi request reprint Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy
    Victor J Gonzalez
    Florida State University College of Medicine, Tallahassee, FL, USA
    Int J Radiat Oncol Biol Phys 65:284-90. 2006
    ..To evaluate two different techniques for whole-breast treatments delivered using the Hi-ART II tomotherapy device...
  78. ncbi request reprint Characterization and use of EBT radiochromic film for IMRT dose verification
    Omar A Zeidan
    Department of Radiation Physics, M D Anderson Cancer Center Orlando, 1400 South Orange Avenue, MP 730, Orlando, Florida 32806, USA
    Med Phys 33:4064-72. 2006
    ..Based on this study, we show that EBT film has several favorable features that allow for its use in routine IMRT patient-specific QA...